147 Stories, most recent news story added Fri Nov 27, 12:00 pm ET
Hanoi - A 23-year-old man has died of avian influenza, bringing Vietnam's bird-flu death toll to five this year, health officials said Tuesday, also confirming two more deaths from swine flu. The Ministry of Health reported the man, from the north-we...
Study: H5N1 needs double mutation to gain human transmissibility A team of British and American researchers say their experiments suggest that the H5N1 avian influenza virus would have to undergo at least two simultaneous mutations to gain the ability to spread easily from human to human.
Bird flu viruses would have to make at least two simultaneous genetic mutations before they could be transmitted readily from human to human, according to research published today in PLoS ONE.The authors of the new study, from Imperial College London, the University of Reading and the University of North Carolina, USA, argue that it is very unlikely that two genetic mutations would occur at the ...
After a lethal bird flu virus emerged in Asia, U.S. officials launched an intense effort to build new defenses against a pandemic, including replacing an antiquated vaccine system, which depends on millions of chicken eggs.
Biotech firm Replikins Ltd. today issued its latest biochemical analysis of the H1N1 virus genomic data. It shows that the lethality of the virus has dropped from its peak of 3.7 (s.d. 4.5) during the virus's current outbreak in the spring of 2009 to resting non-epidemic levels this week of 2.0 (s.d. 0.1). The H1N1 infectivity count, however, remains increased.
Medicago Inc. , a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced its operational and financial results for the third quarter ended September 30, 2009.
Controlling an outbreak of H5N1 Avian Flu, SARS, or BSE is becoming a reality thanks to patentable tracking technologies emerging from AgroMicron, Ltd. [PR.com - September 02, 2006]
Why mall Santas do need the H1N1 vaccine.
BOSTON, Nov. 25 /PRNewswire/ -- Biotech firm Replikins Ltd., which has analyzed the H1N1 virus' genomic data from the 1918 pandemic through the prediction, outbreak, and progress of the current H1N1 pandemic, today issued its latest biochemical analysis of the virus.
BEIJING, Nov. 25 /PRNewswire-Asia/ -- Sinovac Biotech Ltd.
Reportlinker.com announces that a new market research report is available in its catalogue:
HOLLY SPRINGS, N.C. -(Dow Jones)- Swiss drug maker Novartis AG (NVS, NOVN.VX) opened a vaccine-manufacturing plant Tuesday designed to make influenza vaccines without relying on decades-old technology that employs millions of chicken eggs to grow viruses.
Nov 24, 2009 (CIDRAP News) – The era of cell-based influenza vaccine production in the United States seemed to move closer today as Novartis unveiled its new, nearly billion-dollar manufacturing plant in Holly Springs, N.C., but onshore production and marketing of cell-based vaccines remains a few years away.
GlaxoSmithKline (GSK) today announced that over 40 million doses of its adjuvanted pandemic H1N1 vaccine have been distributed to countries globally for use in government-initiated vaccination programmes.
Cover your sneezes. Stay home if you are sick. Wash those hands. -- read more
Swine flu circulation in Oklahoma may have hit its peak — at least for now, health officials say.
